Search results for "Avtozma"

FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients

FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients

Celltrion announced on October 7 that the U.S. Food and Drug Administration has approved an expanded pediatric indication for the intravenous...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market

Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market

Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines Agency for CT-P55, a biosimilar...